This review focuses on mechanism of action, dosing, precautions and drug interactions, comparison with pegfilgrastim and some key studies. Expert commentary is provided by Professor Michael Green, Director of Cancer Services at Western Health and, Clinical Professor of Medicine at the University of Melbourne as well as a Consultant Medical Oncologist at Peter MacCallum Cancer Centre.
Please login below to download this issue (PDF)